Aprogen Biologics

003060 · KOSPI · ₩003060 · 에이프로젠바이오로직스

₩1,394▲ ₩7 (0.50%)End-of-day · Oct 28, 2026 · End-of-day prices.
Trade
Alert me

Income statement

20252024202320222021
Revenue₩73B₩67B₩87B₩65B₩56B
Cost of sales₩100B₩75B₩99B₩38B₩31B
Gross profit−₩27B−₩7.6B−₩12B₩27B₩25B
Operating income−₩60B−₩53B−₩57B−₩5.4B−₩3.8B
Net income−₩168B−₩105B−₩115B₩5.6B₩9.2B
Net income to shareholders−₩170B−₩105B−₩118B₩7.8B₩8.1B

Balance sheet

20252024202320222021
Total assets₩587B₩591B₩589B₩676B₩615B
Current assets₩155B₩115B₩85B₩241B₩353B
Cash and equivalents₩24B₩12B₩10B₩24B₩35B
Total liabilities₩309B₩212B₩221B₩174B₩17B
Current liabilities₩229B₩148B₩158B₩161B₩9.4B
Borrowings₩208B₩136B₩161B₩134B₩2.2B
Total equity₩278B₩379B₩369B₩502B₩597B
Shareholders' equity₩208B₩378B₩369B₩422B₩508B

Cash flow

20252024202320222021
Cash from operations−₩38B−₩31B−₩34B₩26B−₩6.2B
Capital spending₩9.6B₩15B₩28B₩1.3B₩796M
Free cash flow−₩48B−₩46B−₩62B₩24B−₩7B
Dividends paid₩84,588————

Consolidated where available. Amounts in won.

Also known as: Aprogen Biologics / 에이프로젠바이오로직스 / 003060 / KRX:003060

Source: KRX statistical information